Literature DB >> 9195304

Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium.

Y Hori1, J Hoshino, C Yamazaki, T Sekiguchi, S Miyauchi, S Mizuno, K Horie.   

Abstract

Lecithinized-superoxide dismutase (PC-SOD), which is synthesized with a lecithin derivative bound covalently to recombinant human Cu,Zn-SOD, has a longer half-life in blood and higher cell affinity than unmodified SOD. The effects of PC-SOD were evaluated using the rat ulcerative colitis model induced by 3% dextran sulfate sodium. Intravenous injection of rats with 0.5 or 1 mg/kg of PC-SOD suppressed the progression of bloody stools, the formation of erosion, and the infiltration of the colon with inflammatory cells. Furthermore, it also reduced the increase of leukocytes in blood. Thus, PC-SOD may have therapeutic potential in the treatment of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195304     DOI: 10.1254/jjp.74.99

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

Review 1.  Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

Authors:  L Kruidenier; H W Verspaget
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

2.  A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis.

Authors:  Y Suzuki; T Matsumoto; S Okamoto; T Hibi
Journal:  Colorectal Dis       Date:  2008-02-21       Impact factor: 3.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.